- $402.89m
- $78.07m
- 42
- 40
- 52
- 41
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.115 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 23.2 | 51.5 | 86.4 | 119 | 132 |
Operating Profit | -23.1 | -51.5 | -86.4 | -119 | -132 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -21.1 | -91.4 | -86.1 | -114 | -118 |
Net Income After Taxes | -21.1 | -91.4 | -86.1 | -114 | -118 |
Net Income Before Extraordinary Items | |||||
Net Income | -21.1 | -91.4 | -86.1 | -114 | -118 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -21.1 | -91.4 | -86.1 | -114 | -118 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.668 | -2.8 | -2.62 | -2.61 | -2.31 |
Dividends per Share |